Human gut microbiota and its relationship to health and disease

Taylor C. Wallace, Francisco Guarner, Karen Madsen, Michael D. Cabana, Glenn Gibson, Eric Hentges, Mary Ellen Sanders

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Probiotics are live microorganisms that confer a health benefit on the host when administered in appropriate amounts. Over 700 randomized, controlled, human studies have been conducted with probiotics thus far, with the results providing strong support for the use of probiotics in the clinical prevention or treatment of gastrointestinal tract disorders and metabolic syndrome. The present review is based on webinar presentations that were developed by the American Gastroenterological Association (AGA) in partnership with the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the North American branch of the International Life Sciences Institute (ILSI North America). The presentations provided gastroenterologists and researchers with fundamental and current scientific information on the influence of gut microbiota on human health and disease, as well as clinical intervention strategies and practical guidelines for the use of probiotics and prebiotics.

Original languageEnglish (US)
Pages (from-to)392-403
Number of pages12
JournalNutrition Reviews
Volume69
Issue number7
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Probiotics
Health
Prebiotics
Biological Science Disciplines
Insurance Benefits
North America
Gastrointestinal Tract
Research Personnel
Gastrointestinal Microbiome
Guidelines

Keywords

  • Clinical guidelines
  • Gut microbiota
  • Health
  • Intervention
  • Prebiotic
  • Probiotic

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Wallace, T. C., Guarner, F., Madsen, K., Cabana, M. D., Gibson, G., Hentges, E., & Sanders, M. E. (2011). Human gut microbiota and its relationship to health and disease. Nutrition Reviews, 69(7), 392-403. https://doi.org/10.1111/j.1753-4887.2011.00402.x

Human gut microbiota and its relationship to health and disease. / Wallace, Taylor C.; Guarner, Francisco; Madsen, Karen; Cabana, Michael D.; Gibson, Glenn; Hentges, Eric; Sanders, Mary Ellen.

In: Nutrition Reviews, Vol. 69, No. 7, 01.07.2011, p. 392-403.

Research output: Contribution to journalArticle

Wallace, TC, Guarner, F, Madsen, K, Cabana, MD, Gibson, G, Hentges, E & Sanders, ME 2011, 'Human gut microbiota and its relationship to health and disease', Nutrition Reviews, vol. 69, no. 7, pp. 392-403. https://doi.org/10.1111/j.1753-4887.2011.00402.x
Wallace, Taylor C. ; Guarner, Francisco ; Madsen, Karen ; Cabana, Michael D. ; Gibson, Glenn ; Hentges, Eric ; Sanders, Mary Ellen. / Human gut microbiota and its relationship to health and disease. In: Nutrition Reviews. 2011 ; Vol. 69, No. 7. pp. 392-403.
@article{3c618eb0ad3a4bdd9d61da4f003772e3,
title = "Human gut microbiota and its relationship to health and disease",
abstract = "Probiotics are live microorganisms that confer a health benefit on the host when administered in appropriate amounts. Over 700 randomized, controlled, human studies have been conducted with probiotics thus far, with the results providing strong support for the use of probiotics in the clinical prevention or treatment of gastrointestinal tract disorders and metabolic syndrome. The present review is based on webinar presentations that were developed by the American Gastroenterological Association (AGA) in partnership with the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the North American branch of the International Life Sciences Institute (ILSI North America). The presentations provided gastroenterologists and researchers with fundamental and current scientific information on the influence of gut microbiota on human health and disease, as well as clinical intervention strategies and practical guidelines for the use of probiotics and prebiotics.",
keywords = "Clinical guidelines, Gut microbiota, Health, Intervention, Prebiotic, Probiotic",
author = "Wallace, {Taylor C.} and Francisco Guarner and Karen Madsen and Cabana, {Michael D.} and Glenn Gibson and Eric Hentges and Sanders, {Mary Ellen}",
year = "2011",
month = "7",
day = "1",
doi = "10.1111/j.1753-4887.2011.00402.x",
language = "English (US)",
volume = "69",
pages = "392--403",
journal = "Nutrition Reviews",
issn = "0029-6643",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Human gut microbiota and its relationship to health and disease

AU - Wallace, Taylor C.

AU - Guarner, Francisco

AU - Madsen, Karen

AU - Cabana, Michael D.

AU - Gibson, Glenn

AU - Hentges, Eric

AU - Sanders, Mary Ellen

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Probiotics are live microorganisms that confer a health benefit on the host when administered in appropriate amounts. Over 700 randomized, controlled, human studies have been conducted with probiotics thus far, with the results providing strong support for the use of probiotics in the clinical prevention or treatment of gastrointestinal tract disorders and metabolic syndrome. The present review is based on webinar presentations that were developed by the American Gastroenterological Association (AGA) in partnership with the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the North American branch of the International Life Sciences Institute (ILSI North America). The presentations provided gastroenterologists and researchers with fundamental and current scientific information on the influence of gut microbiota on human health and disease, as well as clinical intervention strategies and practical guidelines for the use of probiotics and prebiotics.

AB - Probiotics are live microorganisms that confer a health benefit on the host when administered in appropriate amounts. Over 700 randomized, controlled, human studies have been conducted with probiotics thus far, with the results providing strong support for the use of probiotics in the clinical prevention or treatment of gastrointestinal tract disorders and metabolic syndrome. The present review is based on webinar presentations that were developed by the American Gastroenterological Association (AGA) in partnership with the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the North American branch of the International Life Sciences Institute (ILSI North America). The presentations provided gastroenterologists and researchers with fundamental and current scientific information on the influence of gut microbiota on human health and disease, as well as clinical intervention strategies and practical guidelines for the use of probiotics and prebiotics.

KW - Clinical guidelines

KW - Gut microbiota

KW - Health

KW - Intervention

KW - Prebiotic

KW - Probiotic

UR - http://www.scopus.com/inward/record.url?scp=79960067123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960067123&partnerID=8YFLogxK

U2 - 10.1111/j.1753-4887.2011.00402.x

DO - 10.1111/j.1753-4887.2011.00402.x

M3 - Article

C2 - 21729093

AN - SCOPUS:79960067123

VL - 69

SP - 392

EP - 403

JO - Nutrition Reviews

JF - Nutrition Reviews

SN - 0029-6643

IS - 7

ER -